Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan G Duda

Showing results (11-20 of 261) with videos related to

Pageof 27
Sort By:
The Lancet. Oncology|September 1, 2025
A GOLP rush in biliary tract cancer: early promise in the quest for curative surgeryDan G Duda, Milind Javle
Gut|June 30, 2022
Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?Satoru Morita, Dan G Duda
Cancer Research|July 1, 2010
Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?Dan G Duda, Rakesh K Jain
The Journal of Clinical Investigation|March 15, 2005
Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrowDan G Duda, Rakesh K Jain
Cancer Cell|July 5, 2003
Role of bone marrow-derived cells in tumor angiogenesis and treatmentRakesh K Jain, Dan G Duda
Hepatology (Baltimore, Md.)|September 19, 2023
Scirrhous HCC: Another 'omic thread in the HCC tapestryJoseph W Franses, Dan G Duda
Oncology (Williston Park, N.Y.)|September 11, 2012
Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: what should be the priority?Dan G Duda, Christopher G Willett
Cancer Research|October 17, 2022
Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of SorafenibDan G Duda, Rakesh K Jain
Trends in Molecular Medicine|May 28, 2004
Role of eNOS in neovascularization: NO for endothelial progenitor cellsDan G Duda, Dai Fukumura, Rakesh K Jain
Cancer Journal (Sudbury, Mass.)|June 8, 2015
Lessons From 30 Years of Teaching About the Microenvironment of TumorsRakesh K Jain, Dai Fukumura, Dan G Duda
Pageof 27

Showing results (11-20 of 261) with videos related to

Sort By:
Pageof 27
The Lancet. Oncology|September 1, 2025
A GOLP rush in biliary tract cancer: early promise in the quest for curative surgeryDan G Duda, Milind Javle
Gut|June 30, 2022
Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?Satoru Morita, Dan G Duda
Cancer Research|July 1, 2010
Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?Dan G Duda, Rakesh K Jain
The Journal of Clinical Investigation|March 15, 2005
Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrowDan G Duda, Rakesh K Jain
Cancer Cell|July 5, 2003
Role of bone marrow-derived cells in tumor angiogenesis and treatmentRakesh K Jain, Dan G Duda
Hepatology (Baltimore, Md.)|September 19, 2023
Scirrhous HCC: Another 'omic thread in the HCC tapestryJoseph W Franses, Dan G Duda
Oncology (Williston Park, N.Y.)|September 11, 2012
Going beyond systemic fluoropyrimidines with radiation therapy for rectal cancer: what should be the priority?Dan G Duda, Christopher G Willett
Cancer Research|October 17, 2022
Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of SorafenibDan G Duda, Rakesh K Jain
Trends in Molecular Medicine|May 28, 2004
Role of eNOS in neovascularization: NO for endothelial progenitor cellsDan G Duda, Dai Fukumura, Rakesh K Jain
Cancer Journal (Sudbury, Mass.)|June 8, 2015
Lessons From 30 Years of Teaching About the Microenvironment of TumorsRakesh K Jain, Dai Fukumura, Dan G Duda
Pageof 27